Compare Stocks → $25,000 into $109,616 in two months? (From WealthPress) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison CVE:CXVNYSE:EHC Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeCXVBLVD CentersC$0.07+∞C$0.07C$0.05▼C$0.18C$16.28MN/A1.10 million shs1.59 million shsEHCEncompass Health$82.60+6.3%$74.10$52.56▼$83.73$8.27B0.93633,871 shs1.86 million shsBeginner's Guide to Pot Stock InvestingClick the link below and we'll send you MarketBeat's guide to pot stock investing and which pot companies show the most promise. Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceCXVBLVD Centers0.00%0.00%0.00%0.00%0.00%EHCEncompass Health+1.21%+1.36%+3.05%+15.54%+47.62%Claim Your Complimentary Bitcoin Reward (Ad)Many have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot NowMarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationCXVBLVD CentersN/AN/AN/AN/AN/AN/AN/AN/AEHCEncompass Health4.738 of 5 stars2.63.01.75.02.51.72.5Analyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceCXVBLVD CentersN/AN/AN/AN/AEHCEncompass Health3.13Buy$83.220.75% UpsideCurrent Analyst RatingsLatest CXV, CMBN, and EHC Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/28/2024EHCEncompass HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetOverweight ➝ Overweight$95.00 ➝ $101.003/6/2024EHCEncompass HealthBarclaysSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageOverweight$95.002/9/2024EHCEncompass HealthTruist FinancialSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$82.00 ➝ $86.002/9/2024EHCEncompass HealthRoyal Bank of CanadaSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform ➝ Outperform$83.002/9/2024EHCEncompass HealthMizuhoSubscribe to MarketBeat All Access for the recommendation accuracy ratingBoost Price TargetBuy ➝ Buy$77.00 ➝ $82.002/7/2024EHCEncompass HealthWilliam BlairSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOutperform1/16/2024EHCEncompass HealthStephensSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingOverweight ➝ Overweight$85.00(Data available from 3/28/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookCXVBLVD CentersN/AN/AN/AN/AN/AN/AEHCEncompass Health$4.80B1.72$7.01 per share11.79$22.50 per share3.67Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateCXVBLVD CentersN/AN/A0.00∞N/AN/AN/AN/AN/AEHCEncompass Health$352M$3.4723.8018.731.427.33%17.69%6.24%4/25/2024 (Estimated)Latest CXV, CMBN, and EHC EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails2/7/2024Q4 2023EHCEncompass Health$0.83$0.95+$0.12$1.04$1.24 billion$1.25 billionDividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthCXVBLVD CentersN/AN/AN/AN/AN/AEHCEncompass Health$0.600.73%-18.78%17.29%N/ALatest CXV, CMBN, and EHC DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date2/28/2024EHCEncompass Healthquarterly$0.150.8%3/28/20244/1/20244/15/2024(Data available from 1/1/2013 forward)DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioCXVBLVD CentersN/AN/AN/AEHCEncompass Health1.191.281.28OwnershipInstitutional OwnershipCompanyInstitutional OwnershipCXVBLVD CentersN/AEHCEncompass Health97.25%Insider OwnershipCompanyInsider OwnershipCXVBLVD CentersN/AEHCEncompass Health1.90%MiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableCXVBLVD CentersN/A232.62 millionN/ANot OptionableEHCEncompass Health38,000100.14 million98.24 millionOptionableCXV, CMBN, and EHC HeadlinesSourceHeadlineEncompass Health (NYSE:EHC) Hits New 52-Week High After Analyst Upgrademarketbeat.com - March 28 at 10:30 AMBuy Rating Affirmed for Encompass Health Amid Regulatory Relief and Strong Fundamentalsmarkets.businessinsider.com - March 28 at 9:26 AMEncompass Health Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)markets.businessinsider.com - March 28 at 9:26 AMBarclays Raises Encompass Health (NYSE:EHC) Price Target to $101.00marketbeat.com - March 28 at 8:28 AMEncompass Health (NYSE:EHC) Releases FY 2024 Earnings Guidancemarketbeat.com - March 28 at 7:05 AMEncompass Health announces Andrew Baird as senior vice president of public policy, legislation and regulationsprnewswire.com - March 27 at 4:30 PMEncompass Health (EHC) is a Top-Ranked Value Stock: Should You Buy?zacks.com - March 27 at 10:46 AMFort Washington Investment Advisors Inc. OH Acquires 58,150 Shares of Encompass Health Co. (NYSE:EHC)marketbeat.com - March 26 at 11:09 AMNordea Investment Management AB Raises Holdings in Encompass Health Co. (NYSE:EHC)marketbeat.com - March 23 at 4:44 AMCritical Survey: Encompass Health (NYSE:EHC) versus CareRx (OTCMKTS:CHHHF)americanbankingnews.com - March 22 at 1:28 AMWhy Encompass Health (EHC) is a Top Growth Stock for the Long-Termzacks.com - March 18 at 10:51 AMEncompass Health (EHC) Up 42% in a Year: What Lies Ahead?zacks.com - March 15 at 1:51 PMTeachers Retirement System of The State of Kentucky Acquires 13,352 Shares of Encompass Health Co. (NYSE:EHC)marketbeat.com - March 15 at 7:54 AMWellington Management Group LLP Sells 1,225,868 Shares of Encompass Health Co. (NYSE:EHC)marketbeat.com - March 14 at 6:47 AMAn In-Depth Analysis of Encompass Health's (EHC) 2024 Outlookzacks.com - March 12 at 12:16 PMEncompass Health reiterates 2024 guidancemsn.com - March 12 at 4:55 AMEncompass plans Georgia hospitalbizjournals.com - March 11 at 5:40 PMEncompass Health (NYSE:EHC) Issues FY24 Earnings Guidancemarketbeat.com - March 11 at 5:08 PMEncompass Health (EHC), Piedmont to Build Loganville Facilityzacks.com - March 11 at 1:51 PMHere's Why Encompass Health (EHC) is a Strong Value Stockzacks.com - March 11 at 10:46 AMEncompass Health Co. (NYSE:EHC) Shares Purchased by Sei Investments Co.marketbeat.com - March 11 at 7:11 AMGSA Capital Partners LLP Makes New Investment in Encompass Health Co. (NYSE:EHC)marketbeat.com - March 9 at 7:47 AMWhy Is Encompass Health (EHC) Up 5.3% Since Last Earnings Report?zacks.com - March 8 at 12:36 PMEncompass Health (NYSE:EHC) Reaches New 1-Year High at $77.98marketbeat.com - March 7 at 11:29 AMNew MarketBeat Followers Over TimeMedia Sentiment Over TimeCompany DescriptionsBLVD CentersCVE:CXVBLVD Centers Corporation provides detoxification and outpatient rehabilitation services. It operates rehabilitation centers under the BLVD Centers brand name in Los Angeles, Orange County, Corona, and San Diego, California; and Portland, Oregon. The company was formerly known as Convalo Health International, Corp. and changed its name to BLVD Centers Corporation in June 2017. BLVD Centers Corporation was incorporated in 2013 and is headquartered in Los Angeles, California.Encompass HealthNYSE:EHCEncompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions. It offers services through the Medicare program to federal government, managed care plans and private insurers, state governments, and other patients. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. The company was incorporated in 1984 and is based in Birmingham, Alabama. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.